News
Chemspec Europe 2024 – A World of Fine & Specialty Chemicals
If you are looking to connect with a spectrum of fine as well as specialty chemicals, you ought to be at Chemspec Europe 2024.
We present to you the last chance to get your spot at a 50% discount, as...
News
Gerresheimer expands capacities for Medical Systems in the USA
Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries, is significantly expanding its production capacities for medical systems such as inhalers and autoinjectors in the United States. In two expansion stages,...
Drug Research
Roche and Hitachi High-Tech extend their 46-year partnership, paving the way for further breakthroughs in diagnostic testing
Roche announced that Hitachi High-Tech and Roche have extended their partnership, committing to at least 10 years of additional collaboration. Bringing together the companies' expertise and track record in diagnostics innovation, engineering and manufacturing, the renewed contract further strengthens...
Drug Research
FDA Grants Roche Tina-qant Lp Assay Breakthrough Device Designation – a key marker for hereditary cardiovascular risk
Roche announced that the Tina-quant® lipoprotein Lp(a) RxDx assay has received Breakthrough Device Designation from the U.S. FDA to identify patients who may benefit from innovative Lp(a)-lowering therapy currently in development. Lp(a) is emerging as an important, yet under-recognised,...
News
UPS Healthcare Opens Logistics Facility in Dublin with EUR 12 Million Investment
UPS Healthcare has announced the opening of a first-of-its-kind healthcare logistics facility in Dublin. This EUR 12 million investment covers nearly 6,000 m² and has created 30 new jobs, demonstrating UPS's commitment to the Irish market and export growth.
The...
News
AbbVie Completes Acquisition of Landos Biopharma
AbbVie announced that it has completed its acquisition of Landos Biopharma, Inc With the completion of the acquisition, Landos is now part of AbbVie.
Landos' lead investigational asset is NX-13, a first-in-class, oral NLRX1 agonist (a member of the NOD-like...
News
Florida’s Efforts to Address Medication for Anxiety and Depression
Feeling overwhelmed by anxiety or depression can push you toward quick fixes like alcohol or drugs. These might offer temporary relief but can lead to dependence and bigger problems. Florida is actively working to provide better solutions for medication...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read